Effects of Exergames on Muscle and Lung Function in Elderly

April 8, 2025 updated by: Chen Yen-Huey, Chang Gung University

Effects of Exergames on Muscle Strength and Lung Function in Elderly

The goal of this study is to examine the effects of 8-weeks exergames program on pulmonary function, muscle strength and cognitive function in elderly.

Participants will:

Play exergame 30min/session, 2 sessions/week or remained regular daily activities for 8 weeks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Subjects who are older than 60 years will be assigned to exergame group or control group randomly.

Exergame group: Subjects will receive exergame program 30min/session, 2 sessions/week for 8 weeks.

Control group: Subjects remain regular daily activities for 8 weeks. Both groups receive pre- and post- measurements. The measurements included assessment of muscle strength and lung function.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • TaoYuan City, Taiwan, 333
        • Chang Gung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. age > 60 years,
  2. sufficient cognitive capacity to provide informed consent,
  3. ability to understand and speak Chinese or Taiwanese.

Exclusion Criteria:

  1. medical conditions prohibiting physical exercise
  2. physical or cognitive disabilities preventing participation in or comprehension of the exergame.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: exergame
playing exergame 30 min/session, 2 sessions/ week, for 8 weeks.
Other: exergame
playing exergames
No Intervention: Control
remain regular activities for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
forced expiratory volume at 1 sec (L)
Time Frame: week 0 and week 8
forced expiratory volume at 1sec
week 0 and week 8
forced expiratory volume at 1 sec (%)
Time Frame: week 0 and week 8
percentage of forced expiratory volume at 1sec predicted value
week 0 and week 8
forced vital capacity(L)
Time Frame: week 0 and week 8
forced vital capacity
week 0 and week 8
forced vital capacity(%)
Time Frame: week 0 and week 8
percentage of forced vital capacity predicted value
week 0 and week 8
arm curl test
Time Frame: week 0 and week 8
measurement upper arm muscle strength
week 0 and week 8
hand grip strength
Time Frame: week 0 and week 8
measurement upper arm muscle strength
week 0 and week 8
Mini-Mental State Examination
Time Frame: week 0 and week 8
assessment of cognitive function
week 0 and week 8
Montreal Cognitive Assessment
Time Frame: week 0 and week 8
assessment of cognitive function
week 0 and week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chang Gung University

Investigators

  • Principal Investigator: Yen-Huey Chen, PhD, Chang Gung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2023

Primary Completion (Actual)

December 29, 2023

Study Completion (Actual)

December 29, 2023

Study Registration Dates

First Submitted

March 31, 2025

First Submitted That Met QC Criteria

April 8, 2025

First Posted (Actual)

April 10, 2025

Study Record Updates

Last Update Posted (Actual)

April 10, 2025

Last Update Submitted That Met QC Criteria

April 8, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202301151B0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all collected IPD, that underlie results in a publication

IPD Sharing Time Frame

2025/01-2025/06

IPD Sharing Access Criteria

Data are available from the PI upon reasonable request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on exergame

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe